10 — 9 (47) 2022 — Nazarova N.O., Jabbarov A.A., EVALUATION OF THE RESULTS OF BIOCHEMICAL AND INSTRUMENTAL EXAMINATION IN THE DEVELOPMENT OF LUPUS NEPHRITIS

EVALUATION OF THE RESULTS OF BIOCHEMICAL AND INSTRUMENTAL EXAMINATION IN THE DEVELOPMENT OF LUPUS NEPHRITIS

Nazarova N.O.,

Jabbarov A.A.,

Resume

In order to study the influence of various factors on the pathogenetic aspects of the development of LN and changes in kidney function, biochemical (urea, creatinine, total cholesterol, triglyceride, high-density lipoproteins, low-density lipoproteins microalbumin), hemodynamic (dopplerography of renal vessels, EchoCG) vessels, daily monitoring of blood pressure) and determination of the results of the study and evaluation were carried out the results obtained.

Key words: Lyupus nephritis, lipid spectrum, cholesterol, dopplerography of renal vessels, echocardiography.

First page

55

Last page

59

For citation: Nazarova N.O., Jabbarov A.A., EVALUATION OF THE RESULTS OF BIOCHEMICAL AND INSTRUMENTAL EXAMINATION IN THE DEVELOPMENT OF LUPUS NEPHRITIS //New Day in Medicine 9 (47)2022 55- 59 https://l.clck.bar/31294

LIST OF REFERENCES:

1. Verstrepen L., Carpentier I., Beyaert R. The biology of A20-binding inhibitors of NF-kappa B activation (ABINs) Adv Exp Med Biol. 2014; 809:13–31.
2. Caster D.J., Korte EA, Nanda SK, et al. ABIN1 dysfunction as a genetic basis for lupus nephritis. // Journal of the American Society of Nephrology: JASN. 2013; 24(11):1743–1754.
3. Zhou X.J., Cheng F.J., Zhu L., et al. Association of systemic lupus erythematosus susceptibility genes with IgA nephropathy in a Chinese cohort. // Clinical journal of the American Society of Nephrology: CJASN. 2014;9(4):788–797.
4. Lewis M.J., Vyse S., Shields A.M., et al. UBE2L3 polymorphism amplifies NF-kappaB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. // American journal of human genetics. 2015;96(2):221–234.
5. Chung S.A., Taylor K.E., Graham R.R., et al. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. // PLoS genetics. 2011;7(3):e1001323.
6. Шилов Е.М. Волчаночный нефрит: стратегия и лечение. // Тер арх 2006; 5: 76–85.
7. Floto R.A., Clatworthy M.R., Heilbronn K.R., et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. // Nat Med. 2005;11(10):1056–1058.
8. Karassa F.B., Trikalinos T.A., Ioannidis J.P., Fcgamma R.-SLEM-AI Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. // Arthritis Rheum. 2002;46(6):1563–1571.
9. Karassa F.B., Trikalinos T.A., Ioannidis J.P., Fc gamma R-SLEm-ai The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. // Kidney Int. 2003; 63(4):1475–1482.
10. D’Crus. Mycophenolate mofetil of systemic vasculitis. Lupus 2005; 14: 55–7.